Cargando…

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment

OBJECTIVE: Although most HIV-infected individuals achieve undetectable viremia during antiretroviral therapy (ART), a subset have low-level viremia (LLV) of varying duration and magnitude. The impact of LLV on treatment outcomes is unclear. We investigated the association between LLV and virological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elvstam, Olof, Medstrand, Patrik, Yilmaz, Aylin, Isberg, Per-Erik, Gisslén, Magnus, Björkman, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500364/ https://www.ncbi.nlm.nih.gov/pubmed/28683128 http://dx.doi.org/10.1371/journal.pone.0180761

Ejemplares similares

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care
por: Reepalu, Anton, et al.
Publicado: (2017)

Associations Between Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid Levels and Incidence of Invasive Cancer in People With HIV After Initiation of Combination Antiretroviral Therapy
por: Elvstam, Olof, et al.
Publicado: (2021)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study
por: Brattgård, Hanna, et al.
Publicado: (2022)

Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy
por: Botha-Le Roux, Shani, et al.
Publicado: (2022)

High Rates of Virological Suppression in a Cohort of Human Immunodeficiency Virus-Positive Adults Receiving Antiretroviral Therapy in Ethiopian Health Centers Irrespective of Concomitant Tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia
por: Plymoth, Martin, et al.
Publicado: (2020)

Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center–Based Care—Results From a Prospective Cohort Study
por: Reepalu, Anton, et al.
Publicado: (2017)

Drug Resistance in HIV-Positive Adults During the Initial Year of Antiretroviral Treatment at Ethiopian Health Centers
por: Reepalu, Anton, et al.
Publicado: (2021)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV
por: Thorman, Johannes, et al.
Publicado: (2021)

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011)

HIV Virologic Failure among Patients with Persistent Low-Level Viremia in Nairobi, Kenya: It Is Time to Review the >1000 Virologic Failure Threshold
por: Nzivo, Mirriam M., et al.
Publicado: (2023)

Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort
por: Zhang, Tong, et al.
Publicado: (2020)

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
por: Esbjörnsson, Joakim, et al.
Publicado: (2016)

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
por: Yilmaz, Aylin, et al.
Publicado: (2013)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2021)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Nonsuppressible viremia during HIV-1 therapy meets molecular virology
por: Emery, Ann, et al.
Publicado: (2023)

Persistent Low-Level Viremia is an Independent Risk Factor for Virologic Failure: A Retrospective Cohort Study in China
por: Li, Qun, et al.
Publicado: (2021)

The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
por: Weibull Wärnberg, Anna, et al.
Publicado: (2023)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not
por: Beck-Friis, Josefine, et al.
Publicado: (2021)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
por: Gomes, Samara Tatielle M., et al.
Publicado: (2017)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study
por: Yilmaz, Aylin, et al.
Publicado: (2006)

Lived experiences of students with virological failure on antiretrovirals at a university in Limpopo
por: Maphakela, Mahlodi P., et al.
Publicado: (2023)

1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure
por: Fleit, Madeline, et al.
Publicado: (2023)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs
por: Alanko Blomé, Marianne, et al.
Publicado: (2014)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia
por: Arimide, Dawit Assefa, et al.
Publicado: (2022)

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic
por: Reepalu, Anton, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_05pcsildbt46t4uma3kl3d12ji